A Vision of The Future of this World

"But I have many other sheep not of this fold, and these words are true not only of this world. These other sheep also hear and know my voice, and I have promised the Father that they shall all be brought into one fold, one brotherhood of the sons of God. And then shall you all know the voice of one shepherd, the true shepherd, and shall all acknowledge the fatherhood of God."

A VISION OF OUR FUTURE

The few distant tribes who partially survived the downfall of Atlantis (the legends of the 1st Garden of Eden & Dalmatia) each had their original cultural roots in that civilization. Their progeny, and so Eden and Dalmatia thinking, still affects the lives of many present day Earth-dwellers. The world floats on a sea of fire which is gradually dying down, and will become extinguished in a few more million years . . . unless in the meantime mankind probes too deeply into Nature and unleashes the destructive forces of anti matter. Is such a state of affairs building up on Earth today?

A study of history is the looking backward to events and conditions as they were and comparing them with the present era. Time, in terms of years is important only in the sense that man, unable to visualize very far ahead, can best assess human advancement in retrospect. This does not mean that in any generation man can afford not to envision human progress in the millions of generations yet to come.

Life's purpose can only be for the future. Each generation forms the foundation for the progress of those yet unborn. In terms of the human race, retrogression looms ahead unless the course is altered. Warnings have come from all sides. Even divine revelations by the Sons of God yet Ego has prevented this stream of heavenly guidance from having much effect. "Not always shall my spirit strive with man", He has said.

If the life expectancy of the sun is another 48,000,000,000 years it is reasonable to suppose that Earth's life expectancy is at least half of that number of years. However, taking into consideration density, helium content, and rate of usage in comparison to the sun, we might find that the life expectancy Earth is about equal to that of the sun.

The point for questions is; how does the life expectancy of homo-sapiens compare with Earth's life expectancy? At the present rate of deterioration, fostered by illogical breeding habits, mechanization and luxury, led by the lighter skinned races, a further separation of human thought will occur. The dark skinned races will rise to power and shortly afterwards decline when swiftly overtaken by Ego. Through the specialization rule and mass psychology as is still practiced today, the bulk of the human race will degenerate to comfortable slavery status, having all their thinking done for them, and completely dominated by mechanized instruction, to finally lose all power of independent thought or personal drive. They will sink to a low mental level which concentrates only on fleshy comfort and social security.

But for Spirit. Ever and anon, Spiritual Promise is inviolable, He will send messengers, channels for the expression of Divine Wisdom to guide humanity. These will be fully apparent to those with integrity, easily recognizable to the non-egotistical seeker. They will illuminate and lead, helping to maintain the essential balance of nature and spirit. Regardless of nationality, their cities will rise on Earth, first one and then another, to form the nucleus of a new, single Earth-race. Such a city has He shown to me in a vision. The huge structure was formed like a bubble; seamless; having the appearance of plexiglass; of tensile strength beyond anything yet devised on Earth - even impervious to Black Light vibrations.

Inside the outer dome was a second, similar "bubble", with about ten feet of space in between the two shells. Those walking in the intervening space between the shells are able to observe all that goes on beyond the outer shell. But they cannot see into the inner shell, the structural molecules being so balanced that they shift to adjust to light rays either from within or without. A warm hand placed on any part of this shell will immediately feel cold. Showered with any cold substance, the shell will cause that substance to react as though to heat. No air, sunlight, rain, dust, germs or radiation can pierce the outer "bubble". High above and in between the two shells is a form of manufactured daylight, sunlight, and even clouds to fill any psychological requirements of the inhabitants. The air is constantly purified.

Inside the second shell, the dwellings compare with those of the twentieth century, but are built in softer, more curved lines, and are all of the same glass-like material. Gardens bloom in profusion. Flowers, shrubs, trees and individual vegetable gardens are far more in evidence than today. The foliage is far more prominent to the eye of the observer than the actual homes of the people who live there.

Entrance to the City is made through an outer door of the same plexiglass-like material. This door leads onto a ten-foot driveway between the two shells. However, at the entrance a tunnel-like arrangement with three doors greets a visitor. By taking the door to the left of the entrance it would be possible to drive around the entire city and emerge where you started, coming out of the door on the right hand side of the entrance. The centre door gives access to the City proper. But before entering from the outer atmosphere, all are subjected to extensive scrutiny. Possessions, including conveyance, are tested with metal detection and radioactive devices. If the people wishing to enter the city are non-resident, all possessions are left at the entrance, and the visitor is supplied with every requirement for the duration of his visit.

Permanent residents wishing to leave (a rare circumstance) may only do so with a special permit. These people are specially outfitted for the trip into the outerworld, including their "conveyance"; a one piece, completely plastic-like vehicle with no visible working parts.

Nothing but the de-contaminated human body may enter through the inner door, and nothing but a person and their conveyance may leave.

Permission is frequently given for those from the outside world to take a grand circular tour around the driveway which circles the city. At this time none of the previously mentioned precautions apply.

About one mile in a geometrically straight line from the entrance, we find the Administration Building, known locally as The House. From the City's gateway, the main centre driveway is uncluttered by any buildings. It is landscaped to some depth with a glorious array of multi-coloured flora, so artistically designed that it never becomes overbearing or distracting to the senses.

The House, like all others, is of the same material as the shell. It shows only one storey above ground level, and is almost half a mile square, though not actually square in shape.

A long wide terrace, reached by five wide, stone-like steps, dominates the front elevation of the building. Much of this terrace is landscaped with exotically beautiful gardens, with subdued aquariums here and there, glittering from the rays of rare, tropical-like fish. A central fountain of crystal clear water plays its way high into the air.

The terrace is usually occupied by a quiet female figure, who dispenses the colony's needs with exact impartiality. High up, and out of sight to all but the initiated, are a number of instruments similar to today's television sets. They are indeed a form of television which may be tuned into the required channel by pressure on a small button close to the woman's hand. When the image of the required person appeared on the screen, a whispered instruction to that technician could tune in both the image and words of any person living in the world. When required this machine could also relay the image and speech of certain persons from other occupied planets in the Universe. Beneath the main structure of this building are fifteen lower floors which constitute the heart and pulse of the entire city. Here is machinery, refineries, air and water pumps purifiers, smelters, offices . . . everything that is required to sustain life. The whole place is illuminated by an everlasting daylight that creates no shadow and is without visible source

Surprisingly enough from the fifth sub-floor downwards there is no light. Total blackness greets the eye. The workers here, who are not native Earthlings are ebony in colour. They are shaped along somewhat different lines to those of the human form, the main difference being in the head and extremities. These people have developed far beyond man's meager mental capabilities. They are particularly adept at reading magnetic vibrations and keep records of the sayings, schemings and doings of the now decadent outside world. All thought vibrations are monitored within a radius of 300 square miles.

Another innovation is a tubular-type launching pad situated some distance from The House (as the main building is called). This double rocket launching site can be reached by twin tunnels from the fifteenth sub floor and connects to the fifth sub-floor by a chute made up of an endless chain belt conveyance with seats large enough for two passengers. These travel at such a speed that one and a half seconds is all the time required to travel the 165 feet downwards.

From the fifth sub-floor downwards is the domain of the "Ebonites". The temperature in this working area is necessarily maintained at a constant 80° Fahrenheit; one route to the launching site likewise.

Native earthlings rarely visit this area of heat and total darkness, in spite of ample connections between all floors.

The second launching tube is cool and brightly lit, manned by deeply bronzed human operators. The space-ships coming and going from the dual launch site are however, identical. Only the functional interiors differ for the convenience of Passengers.

Space Ships leave and arrive regularly. The "Ebonites" to return to their home planet, the earthlings to tour the accessible parts of the Universe. Interplanetary exchange has long since been established, whereby an Earth-ship might reach a planet carrying a visitor for a further destination whose journey would then be completed by stages, utilizing craft from other worlds.

Visitors would stay at earth-conditioned accommodations through their trip.

But such traveling would be rare, for any human in this period who ventured on such a voyage would have to spend whole lifetime away from his home planet.

To better understand the population of the colony a closer description of its inhabitants might be in order. The earthlings, by intermarriage, had all achieved various bronze skin shading with medium hair colouring.

Interplanetary technician exchange, which insofar as earth was concerned applied only to these "Bubble-Colonies", supplied the "Ebonite" technicians whose skill was foreign to earthlings. In return selected earthlings went to other planets to develop skills peculiar to earthlings. This system was largely responsible for the rapid progress in either place.

The "Ebonites" had quite a large head in comparison with their body. The ears were set high; the eyes were five to six times larger than human eyes with a feline translucence. The nose, as a protuberance did not show, but the mouth was quite large and prominent - similar to the mouths of vegetarian animals on earth, for these people were strict vegetarians. They had no chin. Being accustomed to a home planet where three earth years was as one of their own, each "Ebonite" contracted to spend three years on Earth. This arrangement was absolutely essential, as among this race both the male and female experienced a "heat" period only once every three earth-years. At this time it was necessary that mating take place or the health of the "Ebonite" would be seriously impaired. Very strict records were kept for this purpose; the mating season could be predicted to almost the minute of its commencement and took several hours for completion. Although both male and female workers came to Earth no mating ever took place away from the home planet. No genital organs were normally in evidence. The female breast enlarged only during the nine to ten weeks of her gestation period, and weaning became automatic as they shortly retracted to the normal size of any well developed male. Earthlings found it almost impossible to differentiate between the sexes of the "Ebonites", but between themselves the odour vibrations emitted by the body were quite distinguishable. The "Ebonites" were also very conscious of human odour vibrations and found them not only most distasteful but very loud, so that they would politely contrive to cover both the nose and ears if an earthling was nearby. A great deal of thought and preparation had gone in the foundation of this enclosed city. Conceived by a handful of early pioneers, it is now peopled by a relatively small percentage of the human race, who, through spiritual guidance have elected to live in seclusion.

The state of the outside world has deteriorated to the point where 90% of the population live in an abject state of servitude, dominated by one hundredth of one percent of their total. The remainder live on a somewhat higher plane of thought, but are completely restricted as to freedom of choice These are the essential intellects required by the rulers for scientific knowledge.

Vast amounts of time and energy are spent in bickering between the rulers. This argument is usually termed "Conferences" and "Committees". Territorial zones are set and reset as each group strives for supremacy.

Those within the enclosure, metaphysically minded, and heedful of the future of the whole human race, had tired of such wastage of time, talent and human potential. Having seen the writing on the wall they had chosen to build impregnable cities to which all sincerely peaceful and humble people were welcome. Here alone was it possible to survive the onslaught of mass psychology and warfare. Herein the nucleus of humanity which would survive to Father A GLORIOUS RACE.

Here they waited out the seemingly interminable years. Although the "outsiders" bred in droves they suffered strange new diseases and once in a while held mass war drives to cut down on their numbers. Suicide was also common, both on individual and mass scales. Often after such outbreaks thousands would approach the "Bubble Cities" seeking entrance.

I see this picture in far greater detail than herein described. The characters in my vision actually live, talk and act. Their days are spent in concentrated effort to teach the 'outsiders" peace and love. As their adherents grow in number new cities are formed all over the Earth to accommodate all who wish to participate. Their wisdom is such that any error among themselves is instantly apparent and is given immediate attention.

110:4.6 For many thousands of years, so the records of Jerusem show, in each generation there have lived fewer and fewer beings who could function safely with self-acting Adjusters. This is an alarming picture, and the supervising personalities of Satania look with favor upon the proposals of some of your more immediate planetary supervisors who advocate the inauguration of measures designed to foster and conserve the higher spiritual types of the Urantia races.

As Jesus and the twelve visited with the messengers of the kingdom at Gerasa, one of the Pharisees who believed in him asked this question: "Lord, will there be few or many really saved?" And Jesus, answering, said:

"You have been taught that only the children of Abraham will be saved; that only the gentiles of adoption can hope for salvation. Some of you have reasoned that, since the Scriptures record that only Caleb and Joshua from among all the hosts that went out of Egypt lived to enter the promised land, only a comparatively few of those who seek the kingdom of heaven shall find entrance thereto.

"You also have another saying among you, and one that contains much truth: That the way which leads to eternal life is straight and narrow, that the door which leads thereto is likewise narrow so that, of those who seek salvation, few can find entrance through this door. You also have a teaching that the way which leads to destruction is broad, that the entrance thereto is wide, and that there are many who choose to go this way. And this proverb is not without its meaning. But I declare that salvation is first a matter of your personal choosing. Even if the door to the way of life is narrow, it is wide enough to admit all who sincerely seek to enter, for I am that door. And the Son will never refuse entrance to any child of the universe who, by faith, seeks to find the Father through the Son.

"But herein is the danger to all who would postpone their entrance into the kingdom while they continue to pursue the pleasures of immaturity and indulge the satisfactions of selfishness: Having refused to enter the kingdom as a spiritual experience, they may subsequently seek entrance thereto when the glory of the better way becomes revealed in the age to come. (See the Vision above) And when, therefore, those who spurned the kingdom when I came in the likeness of humanity seek to find an entrance when it is revealed in the likeness of divinity, then will I say to all such selfish ones: I know not whence you are. You had your chance to prepare for this heavenly citizenship, but you refused all such proffers of mercy; you rejected all invitations to come while the door was open. Now, to you who have refused salvation, the door is shut. This door is not open to those who would enter the kingdom for selfish glory. Salvation is not for those who are unwilling to pay the price of wholehearted dedication to doing my Father's will.

When in and  you have turned your backs upon the Father's kingdom, it is useless in  and....  to stand before this door and knock, saying,

'Lord, open to us; we would also be great in the kingdom.' Then will I declare that you are not of my fold. I will not receive you to be among those who have fought the good fight of faith and won the reward of unselfish service in the kingdom on earth.

And when you say, 'Did we not eat and drink with you, and did you not teach in our streets?' then shall I again declare that you are spiritual strangers; that we were not fellow servants in the Father's ministry of mercy on earth; that I do not know you; and then shall the Judge of all the earth say to you: 'Depart from us, all you who have taken delight in the works of iniquity.'

"But fear not; every one who sincerely desires to find eternal life by entrance into the kingdom of God shall certainly find such everlasting salvation. But you who refuse this salvation will some day see the prophets of the seed of Abraham sit down with the believers of the gentile nations in this glorified kingdom to partake of the bread of life and to refresh themselves with the water thereof. And they who shall thus take the kingdom in spiritual power and by the persistent assaults of living faith will come from the north and the south and from the east and the west. And, behold, many who are first will be last, and those who are last will many times be first."



This was indeed a new and strange version of the old and familiar proverb of the straight and narrow way.

 151:4.1 The next day Jesus again taught the people from the boat, saying: "The kingdom of heaven is like a man who sowed good seed in his field; but while he slept, his enemy came and sowed weeds among the wheat and hastened away. And so when the young blades sprang up and later were about to bring forth fruit, there appeared also the weeds. Then the servants of this householder came and said to him: `Sir, did you not sow good seed in your field? Whence then come these weeds?' And he replied to his servants, `An enemy has done this.' The servants then asked their master, `Would you have us go out and pluck up these weeds?' But he answered them and said: `No, lest while you are gathering them up, you uproot the wheat also. Rather let them both grow together until the time of the harvest, when I will say to the reapers, Gather up first the weeds and bind them in bundles to burn and then gather up the wheat to be stored in my barn.'"

151:4.2 After the people had asked a few questions, Jesus spoke another parable: "The kingdom of heaven is like a grain of mustard seed which a man sowed in his field. Now a mustard seed is the least of seeds, but when it is full grown, it becomes the greatest of all herbs and is like a tree so that the birds of heaven are able to come and rest in the branches thereof."

 151:4.3 "The kingdom of heaven is also like leaven which a woman took and hid in three measures of meal, and in this way it came about that all of the meal was leavened."

 151:4.4 "The kingdom of heaven is also like a treasure hidden in a field, which a man discovered. In his joy he went forth to sell all he had that he might have the money to buy the field."

 151:4.5 "The kingdom of heaven is also like a merchant seeking goodly pearls; and having found one pearl of great price, he went out and sold everything he possessed that he might be able to buy the extraordinary pearl."

 151:4.6 "Again, the kingdom of heaven is like a sweep net which was cast into the sea, and it gathered up every kind of fish. Now, when the net was filled, the fishermen drew it up on the beach, where they sat down and sorted out the fish, gathering the good into vessels while the bad they threw away."

 151:4.7 Many other parables spoke Jesus to the multitudes. In fact, from this time forward he seldom taught the masses except by this means. After speaking to a public audience in parables, he would, during the evening classes, more fully and explicitly expound his teachings to the apostles and the evangelists.

*NHS Whistle Blower*

Released 08/07/20.

I am a consultant at a major, regional hospital in Surrey. By major you can take that to indicate that we have an A&E department.

I had agreed to give an interview to an anti lockdown activist in which I would have revealed my identity. I have since changed my mind and only feel able to give an

anonymous statement.

I have changed my mind simply because that all staff, no matter what grade, at all hospitals have been warned that if they give any media interviews at all or make any statements to either the Main Stream Press or smaller, independent press /social media we may, immediately be suspended without pay. I have a family, dependents and I simply cant do it to them. I therefore can not reveal my identity at this time but wish to state as follows:

In my opinion, and that of many of my colleagues, there has been no Covid Pandemic, certainly not in the Surrey region and I have heard from other colleagues this picture is the same throughout the country.

Our hospital would normally expect to see around 350,000 out patients a year.

Around 95,000 patients are admitted to hospital in a normal year and we would expect to see around a similar figure, perhaps 100,000 patients pass through our A&E department.

In the months from March to June (inclusive) we would normally expect to see 100,000 out patients, around 30,000 patients admitted to hospital and perhaps 30,000 pass through A&E. This year (and these figures are almost impossible to get hold of) we are over 95% down on all those numbers.

In effect, the hospital has been pretty much empty for that entire period. At the start, staff that questioned this were told that we were being used as ‘redundant’ capacity, kept back for the ‘deluge’ we were told would come. It never did come, and when staff began to question this, comments like, ‘for the greater good’ and to ‘protect the NHS’ came down from above.

Now its just along the lines of, ‘Shut up or you don’t get paid’. The few Covid cases that we have had, get repeatedly tested, and every single test counted as a new case.

Meaning the figures reported back to ONS / PHE (Office for National Statistics & Public Health England) were almost exponentially inflated. It could be that Covid cases reported by hospitals are between 5 to 10x higher than the real number of cases.

There has been no pandemic and this goes a long way to explain why figures for the UK are so much higher than anywhere else in Europe.

The trust has been running empty ambulances during lockdown and is still doing it now. By this I mean ambulances are driving around, with their emergency alert systems active (sirens & / or lights) with no job to go to.

This I believe has been to give the impression to the public that there is more demand for ambulances than there actually is.

Staff only wear face coverings/ masks & social distance when public facing, as soon as they are out of public view, the masks come off and social distancing is not observed.

Indeed jokes are made about the measures, and I have heard staff express amazement that despite warnings on packets and at point of sales, telling people masks are totally ineffective and dangerous , the public still buy them, because a politician has told them too.

We have cancelled the vast majority of operations and of these ALL elective surgery has been cancelled. That’s surgery that has been pre planned / waiting list.

Non elective Surgery, this tends to be emergency surgery or that which is deemed urgent has been severely curtailed.

The outcome of this is simple.►

People are at best being denied basic medical care and at worst, being left to die, in some cases, in much distress and pain.

Regarding death certification.►

All staff that are responsible for this have been encouraged where possible to put Covid-19 complications as reason for death, even though the patient may have been asymptomatic and also not even tested for covid.

I feel this simply amounts to fraudulently completed death certificates and has been responsible to grossly inflating the number of Covid deaths. The fact is that regardless of what you actually die of in hospital, it is likely that Covid-19 will feature on your death certificate.

I have included with my statement the detailed published guidance from Government on Death Certification which shows how Covid-19, as a factor is encouraged to at least feature on a death certificate. Remember Covid-19 itself can not kill. What kills is complications from the virus, typically pneumonia like symptoms. These complications are in reality incredibly rare but have featured and a large amount of death certificates issued in recent months.

As long as Covid-19 appears on a death certificate, that death is counted as Covid-19 in the figures released by the ONS and PHE. I genuinely believe that many death certificates, especially amongst the older 65+ demographic have been fraudulently completed so as to be counted as Covid-19 deaths when in reality Covid-19 complications did not cause the death.

There have been Thursday nights when I stood, alone in my office and cried as I heard people cheering and clapping outside. It sickens me to see all the ‘Thank You NHS’ signs up everywhere and the stolen rainbow that for me now says one word and word only ; Fear.

There are many good people in the NHS and whilst I do not plead forgiveness for myself, I do plead for them. Most are on low pay, they joined for the right reasons and I did and have been bullied and threatened that if they don’t ‘stay on message’ they don’t eat.

I know that if a way could be found to assure staff within the NHS of safety against reprisals, there would be a tsunami of whistleblowers which I have no doubt would help end this complete and brutal insanity.

I am finding it increasingly hard to live with what I have been involved in and I am sorry this has happened.

To end, I would simply say this.►

Politicians haven’t changed, the country has just made a fatal mistake and started trusting them without question.

499,788 views •
September 7, 2020

Guest on the Plandemic: Indoctornation documentary
Until recently best known as the founder of M·CAM®, the international leader in innovation finance, trade, and intangible asset finance, David E. Martin is a modern day renaissance man, whose roles have included Professor, Lecturer, Chairman and CEO.

From the halls of parliament to HBO comedy and documentary films such as the internationally acclaimed and multi-awarded Patent Wars and Future Dreaming, Dr. Martin takes on some of the world’s most complex economic and social themes using solutions that he’s successfully deployed in his work with over 160 countries.

He recently appeared in Mikki Willis’ documentary, Plandemic: Indoctornation where he revealed the truth behind the vaccine agenda and how following the money had led him to a number of conclusions about what is really going on during the Coronavirus crisis.

With Plandemic: Indoctornation being viewed over 5.7 million times on the Digital Freedom Platform alone, David has become an important voice as part of informed discourse around Coronavirus and our response as a society, with his recent research continuing to focus on vaccines, patents and the role of companies such as Moderna.

David’s other work includes financial engineering and investment, public speaking and writing, he has also served as an advisor to numerous Central Banks, global economic forums, the World Bank and International Finance Corporation and national governments around the world.

He has been instrumental in rebuilding lives and livelihoods in post-conflict, post-colonial, and environmentally devastated regions of the world. He is the architect for the world’s first public equity quantitative market index based on human innovation.

Dr. Martin has publications in law, medicine, engineering, finance, and education. He maintains active research in the fields of linguistic genomics, fractal financial-risk modelling, and cellular membrane ionic signaling. In a televised speech in 2006, David correctly forecast the U.S. housing financial crisis and identified it as a catalyst for the 2008 Global Financial Crisis.

His investment funds, banking businesses and global trade network return extraordinary results by measuring all the field effects of every endeavour. He is also the author of the novel Coup D’Twelve: The Enterprise that Bought the Presidency – now optioned for theatrical release.

Described as a futurist, fulcrum ninja, economist and global business executive, David disarms the most ardent pessimists, showing that with a flexible perspective, we can tackle any perceived problem and achieve extraordinary outcomes.

The Battle for Pandemic Sanity: Hydroxychloroquine Efficacy vs. Its Suppression

(Real-World Research vs. Corporate Profits)

Covid-19 cases are on the rise again in the U.S.

Why are Dr. Anthony Fauci’s NIAID, the FDA, and the CDC so blind to the real-world success of HCQ+azithromycin?  

If this combination is the simple, cheap, safe way to prevent hospitalization, would government agencies, Big Pharma, and the corporate media want to know?

If yes, then the proposed solution from a prominent Yale epidemiologist would prevent hundreds of thousands of deaths, and help the world to recovery.

Real-World Research on Hydroxychloroquine

During February and March of 2020, there was a lot of excitement in the medical community[i] because early indications in China and France seemed to show a cure for people in the early stage of Covid-19. The ancient anti-malarial drug quinine (aka chloroquine, aka hydroxychloroquine, aka HCQ) had been repurposed to show very promising results against Covid-19 when given to outpatients with early symptoms.

On March 21 all that changed when President Donald Trump tweeted:

Hydroxycholoroquine, made from the ancient, cheap, and plentiful anti-malarial drug quinine, had suddenly become highly politicized. Its industry rivals and the media vigorously decried a business president, who, not a doctor, had dashed hopes for a profitable magic-bullet drug by tweeting an almost-free solution.

On May 22, hydroxychloroquine (HCQ), which has been on the WHO list of essential medicines since 1977, was sent into further freefall by a deceptive, industry-backed Lancet article claiming that hydroxychloroquine was causing heart problems in hospitalized Covid patients across six continents.[iii]

Headlines blared, hydroxychloroquine clinical trials were called off, and the World Health Organization recommended that physicians everywhere stop prescribing HCQ for Covid-19.

By May 27, Dr. Harvey Risch, Professor of Epidemiology at the Yale Schools of Public Health and Medicine, had confronted this disaster. He issued an urgent call through the top-ranked American Journal of Epidemiology for hydroxychloroquine + azithromycin “to be widely available and promoted immediately for physicians to prescribe.”[iv]

“Five studies,” he wrote from Yale, “including two controlled clinical trials, had demonstrated significant major outpatient treatment efficacy.” Incredibly, this call for immediate action published in America’s top epidemiology journal did not appear in the mainstream news.[v]

Instead, the opposite occurred. Although international protest drove the Lancet to retract its fraudulent May 22 article on June 4, the retraction made few headlines.  In those two short weeks the U.S. media, with one voice, established HCQ as “controversial,” “anecdotal,” and even “dangerous” when paired with Gilead Science’s highly publicized golden goose, remdesivir.

On May 21, the day before the Lancet’s HCQ attack appeared, the ever-helpful New York Times had issued a timely update of its massive 7,500-word hit piece against Dr. Didier Raoult, the French microbiologist whose published studies in March and April had preceded Yale’s profit-threatening call for sanity.

What was the Covid-HCQ background in China and France?

Dr. Didier Raoult, M.D., PhD., age 68, has long been France’s most cited microbiologist. For 35 years he has been professor of infectious diseases at the Aix-Marseille University in Marseille. Twelve years ago he founded, and is director of, the university’s Institute of Emerging Tropical Diseases.

Raoult is co-author of 2,300 published, peer-reviewed articles, in which he follows classical research standards by stating plagiarism checks, conflict of interest declarations, and funding declarations.

He is married to a psychiatrist and they have three children. In a July 7 BFM-TV interview he said that his philosophy it to treat patients like family.  He also has three laboratories in Senegal, West Africa.

A vacation village near Marseille in Carry le Rouet was used to quarantine French citizens returning from Wuhan in case they needed treatment. President Macron visited Raoult on April 9.

What had Raoult learned from China?

During the early months of the pandemic, Raoult discovered studies from China showing that the repurposed anti-malarial generic drugs chloroquine and hydroxychloroquine were found to be effective in arresting the SARS-CoV-2 coronavirus in vitro (in the laboratory).[vi]

Further Chinese studies followed, including randomized clinical trials, showing that when administered to patients in combination with the antibiotic azithromycin, during the early days of the infection, their symptoms would most often resolve.[vii]

It thus seemed that almost anyone with early symptoms who tested positive could benefit from effective, affordable prophylactic treatment.

Raoult welcomed the people of Marseille for HCQ-azithromycin treatment and they lined up (socially distanced) around the block outside his 200-staff clinic.

This led to published studies. A first group of 80 patients showed a 50-fold benefit, and a larger group of 1,061 patients showed a similar result while achieving a mortality rate of only 0.5% – and with no cardiac toxicity.[viii]

Recent HCQ efficacy studies, unreported by the mainstream media

Two new independent U.S. studies have come to similar conclusions as Dr. Rault in Marseille and Dr. Risch at Yale:

• On July 1, 2020, the Henry Ford Health System in Southeast Michigan reported that a peer-reviewed retrospective study of 2,541 Detroit cases showed up to 71% mortality reduction in early treatment, using HCQ and azithromycin.[ix]
• In a June 30, 2020 study, Dr. Takahisa Mikami and his team at the Icahn School of Medicine, Mount Sinai, New York, analyzed the outcomes of 6493 patients who had confirmed Covid-19 and found that hydroxychloroquine decreased the mortality in hospitalized patients.[x]

The Corporate Profits­ Triad: Big Pharma, Media, Government

The Government arm of the triad

1. Conflicts of interest: the corporate fox in the government henhouse

During recent decades, the health role of government, which is to serve and protect its citizens, has been muddied by increasing corporate representation and influence in higher education and on government advisory committees and foundations. The drug industry, for example, funds university research, pours millions into medical schools, has personnel appointments to university faculties, and supplies textbooks to students.

In 1995 Congress established the private CDC Foundation to support the work of the U.S. Centers for Disease Control and Prevention (CDC).

In public-private partnerships, there is a thin line between support and conflict of interest. Susan Perry writes of the Gilead Tamiflu scandal in 2015:

“Unbeknownst to many, the CDC receives substantial industry funding through the CDC Foundation. A spokesperson said that over the past three years the foundation has received an average of about $6.3 [million] from the industry a year, 21% of the foundation’s overall funding. Since 1995 the foundation has received funding from more than 150 corporate “partners,” including Gilead, which holds the patent on oseltamivir [Tamiflu], as well as Genentech and Roche, the drug’s manufacturers.”[xi]

The creation of the CDC Foundation in 1995 altered the make-up of the highly respected CDC as a purely a tax-supported agency belonging to, and financed by, the people it served.

Dozens of pharmaceutical companies, including Gilead Sciences Inc., contribute millions of dollars to the CDC Foundation each year.[xii]

1. Anthony Fauci’s strange position on hydroxychloroquine

On April 4, a major fight erupted at a meeting of the White House Coronavirus Task Force, when economics advisor Peter Navarro passed around file folders, pointing out that overseas hydroxychloroquine studies showed “clear therapeutic efficacy.” The government’s top infectious diseases specialist, Dr. Anthony Fauci, countered that there was only anecdotal evidence that HCQ works.[xiii]

The evidence above shows that Fauci was wrong.  Navarro was furious and a heated argument ensued.

As the head of the $5.9 billion National Institute of Allergy and Infectious Diseases (NIAID), Fauci should have known better – he should have known about the clinical trials, case reports, and observational studies in the medical literature. And he must certainly have known that it is not ethical to perform placebo-controlled studies during a pandemic:  if the drug saves lives, some of the placebo people will die – a point often made by Professor Raoult.

Nor did Fauci mention real-world treatment guidelines. An April 17 article from the “Elsevier Public Health Emergency Collection” shows that government guidelines in Ireland, Saudi Arabia, and Egypt list chloroquine and hydroxychloroquine as the first line of defense for mild-to-moderate Covid-19. The U.S. guideline listed only remdesivir as the first-line defense.[xiv]

Dr. Fauci should have known about, and mentioned, such national guidelines beyond the United States.

But most particularly, Fauci should have known about the two most critical reasoning aspects regarding hydroxychloroquine:

It is only recommended with azithromycin or doxycycline, and only in an early illness outpatient setting in order to stop the infection before hospitalization becomes necessary.[xv]

The studies above show that this is not rocket science. Why is Dr. Fauci still talking about anecdotal evidence?

Why did he not retract what he told CNN on Wednesday, May 27, referring to what became the May 22 Lancet scandal?

Leaked: “Deadly” Hydroxychloroquine (HCQ) to treat Covid 19: How the World’s Top Medical Journals, The Lancet and NEJM, Were Cynically Exploited by Big Pharma

“Clearly the scientific data is really quite evident now about the lack of efficacy for it.”[xvi]

The corporate arm of the triad: Gilead’s checkered past

To begin with a snapshot of where Gilead’s remdesivir studies stood when on June 29 the US DHSS purchased $1.6 billion worth (500,000 doses, the world supply until the end of August) – the excerpt below from a June 24 article in the British Medical Journal assesses the problems:

“A serious imbalance in covid-19 research strongly favours the study of drug treatments over non-drug interventions, with many studies too small or too weak to produce reliable results.  Equally concerning is the release of partial or preliminary findings before peer review—often through commercial press releases—that is distorting public perceptions, ongoing evaluations efforts, and political responses to the pandemic.

Remdesivir is a key example. The antiviral drug, made by US company Gilead, was unapproved at the start of the pandemic, but in early April the New England Journal of Medicine published a small descriptive study of a compassionate use scheme for patients with covid-19. Gilead funded the study, a third of the authors were Gilead employees, and Gilead’s press release reported “clinical improvement in 68% of patients in this limited dataset.”  Despite being a non-randomised, uncontrolled, company funded study of just 53 patients, media headlines described “hopeful” signs and reported “two thirds” of patients showing improvement.[xvii]

Two weeks later, the Lancet published a randomised placebo controlled trial of remdesivir from China, finding no statistically significant clinical benefit in the primary outcome of time to clinical improvement. Twelve per cent of participants taking remdesivir stopped treatment early because of adverse events, compared with 5% taking placebo. The trial was stopped before meeting recruitment targets.”[xviii]

The only study demonstrating even marginal efficacy shows remdesivir to reduce hospital recovery times 31%, from 15 days to 11 days.[xix]  In light of this benefit, Gilead’s Chairman Daniel Oday explained on June 29 how the company had priced the drug – which had little to do with its cost of $10 per dose to manufacture,[xx] or concern for the cost to the patient, but everything to do with what the market of desperate governments during a pandemic would bear:

“In normal circumstances, we would price a medicine according to the value it provides. The first results from the NIAID study in hospitalized patients with COVID-19 showed that remdesivir shortened time to recovery by an average of four days. Taking the example of the United States, earlier hospital discharge would result in hospital savings of approximately $12,000 per patient. Even just considering these immediate savings to the healthcare system alone, we can see the potential value that remdesivir provides…

We have decided to price remdesivir well below this value. To ensure broad and equitable access at a time of urgent global need, we have set a price for governments of developed countries of $390 per vial. Based on current treatment patterns, the vast majority of patients are expected to receive a 5-day treatment course using 6 vials of remdesivir, which equates to $2,340 per patient…

At the current price of $390 per vial, remdesivir is positioned to achieve the aim of providing immediate net savings for healthcare systems…The price for U.S. private insurance companies, will be $520 per vial. At the level we have priced remdesivir and with government programs in place, along with additional Gilead assistance as needed, we believe all patients will have access.”[xxi]

Incredibly, none of the studies published before this purchase had mentioned side effects of the drug, although in the China study, kidney injury had led to discontinuation for one patient, and in its original use for ebola, liver risks had been identified.[xxii] On July 5­, a public health official reported that “remdesivir is showing reports of liver damage in patients across India.”[xxiii]

On June 30, the day after the DHSS $1.6 billion purchase, an International Journal of Infectious Diseases (IJID) preprint reported that two of five patients in a hospital enrolled in the French Discovery trial had to be put on dialysis for renal insufficiency caused by remdesivir toxicity.[xxiv] That’s 40%.

To summarize the problems with remdesivir:

1. The very few control trials were poorly designed, influenced by vested interests, lacked precision, provided low-quality evidence, or produced negative results.
2. There have been doubts about the regulatory decision of approving it and the purchasing decision to stockpile it.
3. There was little mention of adverse effects in the published literature. Post-marketing surveillance has uncovered adverse effects.

In other words, the benefits behind the purchase were overplayed, and the harms were underplayed.

Sadly, this whole story is a close replica of the costly Tamiflu (antiviral oseltamivir) management disaster that played out during the swine flu H1N1 “pandemic” of 2008-09.[xxv]

On July 2, Christopher Morten, a U.S. patent lawyer – having observed the remdesivir purchase debacle after the government had subsidized the development of the drug – published the article, “A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution.”[xxvi]

Further tax dollars may not be lost.

The media arm of the triad: Remdesivir vs HCQ

Hydroxychloroquine’s days were numbered on March 21 when Donald Trump called it a game changer, and it became terminally ill on May 22 when the prestigious Lancet claimed heart effects on six continents.

Whatever predisposition the media may have had to objectively report the repurposingof a safe old drug had vanished. The battle against it was now framed as the President’s ignorant personal views vs. the reportedly non-existent randomized control trials for a “heart-threatening” drug.

HCQ was losing.

A ray of light shone briefly May 14 with the announcement of a NIAID clinical trial to investigate whether HCQ+azithromycin administered early in illness could prevent hospitalization. However, it was quietly extinguished when the trial suddenly ended June 20, unreported, nine days before the massive remdesivir purchase assailed the headlines June 29.

June 29 was a coordinated victory for corporate interests at the expense of the people’s wellness and their pocketbooks.

Conclusion

Reality in the citizen mind has had nothing to do with all the global HCQ studies that have been withheld from curing hundreds of thousands of people at the first sign of illness.

The coordinated triad network has instead sacrificed thousands of lives by propagandizing people into fearfully believing that once they get really sick, remdesivir helps, whereas HCQ does not.

The public is simply not allowed to know about a well-documented solution that threatens corporate profits and the captured media. (The evidence supporting this claim can be explored in depth at “The Media Sabotage of Hydroxychloroquine Use for COVID-19: Doctors Worldwide Protest the Disaster.”[xxvii])

It seems fitting to conclude on a positive note with these practical, responsible words from Yale epidemiologist Dr. Harvey Risch – words that could well be remembered each day by Dr. Tony Fauci; by the CDC and the FDA; and by any media interested in the public health:

“It is our obligation not to stand by, just ‘carefully watching,’ as the old and infirm and inner city of us are killed by this disease and our economy is destroyed by it and we have nothing to offer except high-mortality hospital treatment.  We have a solution, imperfect, to attempt to deal with the disease.  We have to let physicians employing good clinical judgement use it and informed patients choose it.  There is a small chance that it may not work.  But the urgency demands that we at least start to take that risk and evaluate what happens, and if our situation does not improve we can stop it, but we will know that we did everything that we could instead of sitting by and letting hundreds of thousands die because we did not have the courage to act according to our rational calculations.”[xxviii]

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Notes

[i] “SECOND OPINION: Doctors Discuss the Politicization of Hydroxychloroquine,” June 18, 2020, at 10:21 min. (https://www.youtube.com/watch?time_continue=7&v=m_JIz780i5w&feature=emb_logo).

[ii] Twitter:  https://twitter.com/realDonaldTrump/status/1241367239900778501

[iii] The Lancet, “RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, by Mandeep R. Mehra et al,” Lancet, 5 June 2010 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext).

[iv] Harvey A. Risch, “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis,” Amer. J. Epid, 27 May 2020 (https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586). Risch is Professor at the Yale Schools of both Medicine and Public Health.

[v] Elizabeth Woodworth, “The Media Sabotage of Hydroxychloroquine Use for Covid-19: Doctors Worldwide Protest the Disaster,” Global Research, 30 June 2020 (https://www.globalresearch.ca/media-sabotage-hydroxychloroquine-covid-19-doctors-worldwide-protest-disaster/5717382).

[vi] X. Yao, F. , et al., “In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),”Clin. Infect. Dis.9 March 2020 (online ahead of print:  https://pubmed.ncbi.nlm.nih.gov/32150618/).

Liu, et al., “Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro,” Cell Discov, 18 March 2020 p. 16 (https://pubmed.ncbi.nlm.nih.gov/32194981/),

Wang, et al., “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro,” Cell Res, 30, 4 February 2020, pp. 269-271 (https://www.nature.com/articles/s41422-020-0282-0).

[vii] The Chinese studies are cited in this article: P. Gautret P, et al., “Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study,” Travel Medicine and Infectious Disease, March-April 2020 (https://www.sciencedirect.com/science/article/pii/S1477893920301319).

Chen, et al., “Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial,” MedRxiv, 10 April 2020, awaiting peer review (https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3).

[viii] P. Gautret, et al., “Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study,” Travel Medicine and Infectious Disease, March-April 2020 (https://www.sciencedirect.com/science/article/pii/S1477893920301319).

Matthieu Million, et al., “Early treatment of 1,061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France,”Travel Medicine and Infectious Disease, in press 20 April 2020 (http://santepublique-editions.fr/objects/Article-Raoult-20-avril-2020.pdf).

[ix] Samia Arshad, et al., “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19,” International Journal of Infectious Diseases, 1 July 2020, DOI:https://doi.org/10.1016/j.ijid.2020.06.099(https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext).

[x] Takahisa Mukami, et al., “Risk Factors for Mortality in Patients with COVID-19 in New York City,” J. Gen. Intern. Med., 30 June 2020 (https://pubmed.ncbi.nlm.nih.gov/32607928/).

[xi] Susan Perry, “CDC’s advice to take Tamiflu is compromised by financial conflicts of interest,” MinnPost, 12 February 2015 (https://www.minnpost.com/second-opinion/2015/02/cdcs-advice-take-tamiflu-compromised-financial-conflicts-interest/).

[xii] CDC Foundation, “Our Partners: Foundations.” The following includes a list of CDC Foundation corporate donors and partners over time.”   (https://www.cdcfoundation.org/partner-list/corporations).

[xiii] Jonathan Swan, “Scoop: Inside the epic White House fight over hydroxychloroquine,” Axios, 5 April 2020 (https://www.axios.com/coronavirus-hydroxychloroquine-white-house-01306286-0bbc-4042-9bfe-890413c6220d.html).

[xiv] M. Tobaiqy, et al., “Therapeutic management of patients with Covid-19:  a systematic review,” Infection Prevention in Practice, 17 April 2020 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162768/)

[xv] Harvey A. Risch, “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis,” Amer. J. Epid, 27 May 2020 (https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586). Risch is Professor at the Yale Schools of both Medicine and Public Health.

[xvi] Devan Cole, “Fauci: Science shows hydroxychloroquine is not effective as a coronavirus treatment,” CNN, 27 May 2020 (https://www.cnn.com/2020/05/27/politics/anthony-fauci-hydroxychloroquine-trump-cnntv/index.html).

[xvii] Christopher Rowland, “Gilead’s experimental drug remdesivir shows ‘hopeful’ signs in small group of coronavirus patients,” Washington Post, 10 April 2020 (https://www.washingtonpost.com/business/2020/04/10/gileads-experimental-drug-remdesivir-shows-hopeful-signs-small-group-coronavirus-patients/).

[xviii] Ray Moynihan et al.,“Commercial influence and covid-19,” BMJ2020;369:m2456 (Published 24 June 2020) (https://www.bmj.com/content/369/bmj.m2456).

[xix] Jon Cohen, “Large trial yields strongest evidence yet that antiviral drug can help COVID-19 patients,” Science, 29 April 2020 (https://www.sciencemag.org/news/2020/04/large-trial-yields-strongest-evidence-yet-antiviral-drug-can-help-covid-19-patients).

[xx] Melanie D. Whittington and Jonathan B. Campbell, “Alternative Pricing Models for Remdesivir and Other Potential Treatments for COVID-19,” Institute for Clinical and Economic Review, 1 May 2020 (https://icer-review.org/wp-content/uploads/2020/05/ICER-COVID_Initial_Abstract_05012020-3.pdf). In a May 1, 2020 study, the ICER calculated that the cost of producing the remdesivir “final finished product,” including the pharmaceutical ingredients, formulation, packaging, and a small profit margin, was $9.32 US for a 10-day course of treatment.

[xxi] Daniel Oday, “Press Release:  Open Letter from Chairman Daniel Oday,” Gilead Sciences, 29 June 2020 (https://www.gilead.com/news-and-press/press-room/press-releases/2020/6/an-open-letter-from-daniel-oday-chairman–ceo-gilead-sciences).

[xxii] Crystal Phend, “Remdesivir Safety Forecast: Watch the Liver, Kidneys,” Medpage Today, 19 May 2020 (https://www.medpagetoday.com/infectiousdisease/covid19/86582).

[xxiii] Bindu Shajan Perappadan, “COVID-19 drugs under review after trial results,” The Hindu, 5 July 2020 (https://www.thehindu.com/news/national/covid-19-drugs-under-review-after-trial-results/article31996031.ece).

[xxiv] Marie Dubert and Francois-Xavier Lescure, et al (14 more), “Case reports study of the first five patients COVID-19 treated with remdesivir in France,” International Journal of Infectious Diseases, in press, journal pre-proof, available June 30 online (https://www.sciencedirect.com/S1201971220305282).

[xxv] Yogendra Kumar Gupta, et al., “The Tamiflu fiasco and lessons learnt,” Indian J Pharmacol.2015 Jan-Feb; 47(1): 11–16 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375804/).

[xxvi] Christopher Morten, “A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution,” StatNews, 2 July 2020 (https://www.statnews.com/2020/07/02/powerful-law-gives-hhs-right-to-control-remdesivir-manufacturing-distribution/).

[xxvii] Elizabeth Woodworth, “The Media Sabotage of Hydroxychloroquine Use for COVID-19: Doctors Worldwide Protest the Disaster,” Global Research, June 30 (https://www.globalresearch.ca/media-sabotage-hydroxychloroquine-covid-19-doctors-worldwide-protest-disaster/5717382).

[xxviii] Harvey A. Risch, “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis,” Amer. J. Epid, 27 May 2020 (https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586). Risch is Professor at the Yale Schools of both Medicine and Public Health.

The original source of this article is Global Research

Copyright © Elizabeth Woodworth, Global Research, 2020

GLOBAL RESEARCH DONATE

SOURCE ARTICLE